Dr. Peller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
314 GRASSMARKET
San Antonio, TX 78259Phone+1 507-271-7482Fax+1 210-295-4814
Summary
- Dr. Patrick Peller is a medical consultant based in San Antonio, TX. He completed his internal medicine residency in 1986 at Fitzsimons Army Medical Center, followed by a nuclear medicine residency in 1991 at Walter Reed Army Medical Center. He earned his medical degree from the University of Minnesota Medical School in 1983. Dr. Peller has served as a consultant since 2019 to US and international organizations. His recent publications include topics on PET/CT/MR imaging of neurodegenerative diseases and cancer with many articles widely cited by peers. In the last 3 years, he has been focused on assisting medical start-ups and small businesses to become successful.
Education & Training
National Capital ConsortiumResidency, Nuclear Medicine, 1989 - 1991
Fitzsimons Army Medical CenterResidency, Internal Medicine, 1983 - 1986
University of Minnesota Medical SchoolClass of 1983
Certifications & Licensure
TX State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- Editorial Comment: Highlighting the Opportunity for Advanced Neuroimaging in the Presurgical Evaluation of Adults With Medically Refractory Epilepsy.Patrick J Peller
AJR. American Journal of Roentgenology. 2022-09-01 - 14 citationsInduction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCC...Harry H. Yoon, Fang-Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle
European Journal of Cancer. 2021-06-01 - 10 citations99mTc-Tilmanocept Versus 99mTc-Sulfur Colloid in Lymphoscintigraphy: Sentinel Lymph Node Identification and Patient-Reported PainBrittany L. Murphy, Allison R. Woodwick, Katie Murphy, Kimberly Chandler, Geoffrey B. Johnson
Journal of Nuclear Medicine Technology. 2019-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
